Pharmaceuticals

Advancements and Challenges in Gene Therapy: Dravet Syndrome, Sarepta’s Setback, and AstraZeneca’s Initiatives Dravet syndrome gene therapy

Dravet syndrome gene therapy

Advancements and Challenges in Gene Therapy: Dravet Syndrome, Sarepta’s Setback, and AstraZeneca’s Initiatives

Swati Sharma March 29, 2025

Breakthrough in Dravet Syndrome Gene Therapy Recent research has introduced a promising gene replacement therapy for Dravet...

Novo Nordisk Secures $1 Billion Deal with Lexicon Pharmaceuticals for Innovative Obesity Treatment Novo Nordisk $1 billion deal

Novo Nordisk $1 billion deal

Novo Nordisk Secures $1 Billion Deal with Lexicon Pharmaceuticals for Innovative Obesity Treatment

Swati Sharma March 29, 2025

Introduction In a strategic move to enhance its obesity treatment portfolio, Novo Nordisk has entered into a...

Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease

microbiome treatment for Parkinson's disease

Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease

Gauri Kurdukar February 23, 2023

LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year...